Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279721

Director acquired 29,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DUNCAN BARBARA GAYLE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-18 Exercise or conversion : show line 1 in the form +29,600 92,350 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-06-18 Exercise or conversion : show line 2 in the form Restricted Stock Units −29,600 0 D
2026-06-18 Grant or award : show line 3 in the form Restricted Stock Units +26,700 26,700 D
2026-06-18 Grant or award : show line 4 in the form Stock Option (Right to Buy) +37,700 37,700 D
Loading xslF345X06/ownership.xml…